Zoetis Inc. (ZTS) Stake Lifted by Sei Investments Co.

Sei Investments Co. lifted its holdings in Zoetis Inc. (NYSE:ZTS) by 2.7% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 750,960 shares of the company’s stock after purchasing an additional 20,071 shares during the quarter. Sei Investments Co. owned 0.15% of Zoetis worth $47,882,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds have also bought and sold shares of the company. Northwestern Mutual Wealth Management Co. grew its holdings in shares of Zoetis by 16.8% in the second quarter. Northwestern Mutual Wealth Management Co. now owns 1,598 shares of the company’s stock worth $100,000 after acquiring an additional 230 shares during the period. Harfst & Associates Inc. grew its holdings in shares of Zoetis by 16.1% in the second quarter. Harfst & Associates Inc. now owns 1,878 shares of the company’s stock worth $117,000 after acquiring an additional 260 shares during the period. Almanack Investment Partners LLC. bought a new stake in shares of Zoetis in the second quarter worth $119,000. Peddock Capital Advisors LLC bought a new stake in shares of Zoetis in the second quarter worth $140,000. Finally, Shine Investment Advisory Services Inc. grew its holdings in shares of Zoetis by 86.5% in the third quarter. Shine Investment Advisory Services Inc. now owns 2,242 shares of the company’s stock worth $143,000 after acquiring an additional 1,040 shares during the period. Hedge funds and other institutional investors own 92.90% of the company’s stock.

TRADEMARK VIOLATION WARNING: “Zoetis Inc. (ZTS) Stake Lifted by Sei Investments Co.” was originally reported by The Ledger Gazette and is the property of of The Ledger Gazette. If you are reading this news story on another site, it was illegally stolen and republished in violation of United States and international trademark and copyright legislation. The original version of this news story can be read at https://ledgergazette.com/2017/11/11/zoetis-inc-zts-stake-lifted-by-sei-investments-co.html.

Zoetis Inc. (ZTS) traded down $0.17 during midday trading on Friday, hitting $69.13. The stock had a trading volume of 1,905,700 shares, compared to its average volume of 2,817,385. The company has a market capitalization of $33,769.08, a price-to-earnings ratio of 31.79, a price-to-earnings-growth ratio of 2.03 and a beta of 1.02. The company has a debt-to-equity ratio of 2.45, a quick ratio of 1.95 and a current ratio of 2.80. Zoetis Inc. has a 1 year low of $48.24 and a 1 year high of $70.48.

Zoetis (NYSE:ZTS) last released its quarterly earnings data on Thursday, November 2nd. The company reported $0.65 earnings per share for the quarter, topping analysts’ consensus estimates of $0.63 by $0.02. The firm had revenue of $1.35 billion during the quarter, compared to analyst estimates of $1.32 billion. Zoetis had a return on equity of 62.39% and a net margin of 18.29%. The business’s quarterly revenue was up 8.5% compared to the same quarter last year. During the same quarter in the prior year, the company posted $0.52 earnings per share. sell-side analysts forecast that Zoetis Inc. will post 2.36 earnings per share for the current fiscal year.

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, December 1st. Stockholders of record on Thursday, November 9th will be paid a $0.105 dividend. This represents a $0.42 dividend on an annualized basis and a dividend yield of 0.61%. The ex-dividend date of this dividend is Wednesday, November 8th. Zoetis’s dividend payout ratio (DPR) is 22.11%.

Several analysts recently commented on the company. Morgan Stanley lifted their price objective on Zoetis from $61.00 to $70.00 and gave the stock an “equal weight” rating in a report on Friday, November 3rd. Goldman Sachs Group, Inc. (The) reaffirmed a “neutral” rating and issued a $62.00 price objective on shares of Zoetis in a report on Monday, August 7th. BMO Capital Markets lifted their price objective on Zoetis from $65.00 to $70.00 and gave the stock a “market perform” rating in a report on Friday, November 3rd. Jefferies Group LLC reaffirmed a “buy” rating on shares of Zoetis in a report on Friday. Finally, BidaskClub lowered Zoetis from a “hold” rating to a “sell” rating in a report on Wednesday, November 1st. One research analyst has rated the stock with a sell rating, five have issued a hold rating and twelve have assigned a buy rating to the stock. The company presently has an average rating of “Buy” and an average price target of $67.06.

Zoetis Profile

Zoetis Inc is engaged in the discovery, development, manufacture and commercialization of animal health medicines and vaccines, with a focus on both livestock and companion animals. The Company has a business, commercializing products across eight core species: cattle, swine, poultry, sheep and fish (collectively, livestock) and dogs, cats and horses (collectively, companion animals), and within five product categories: anti-infectives, vaccines, parasiticides, medicated feed additives and other pharmaceuticals.

Institutional Ownership by Quarter for Zoetis (NYSE:ZTS)

Receive News & Ratings for Zoetis Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zoetis Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply